Innovatiefonds Noord-Holland

Name

Innovatiefonds Noord-Holland

Legal name

Innovatiefonds Noord-Holland

Website

https://innovatiefondsnoordholland.nl

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Venture Capital / Regional Investment Fund

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

akta.pro secondary industries

SDG / Thematic Sustainable Investment Funds (FSANAJAN), Water & Waste / Circular Economy Funds (FSANAJAF)

Keywords

• Venture capital fund
• Seed stage financing
• Life sciences investment
• Regional innovation funding
• Convertible loan financing

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Distribution channels1 record

Marketing channels2 records

Core offering

Innovatiefonds Noord-Holland is a regional investment fund that provides early-stage and growth-stage financing to innovative startups and SMEs in the North Holland region of the Netherlands, with a particular focus on the Life Science & Health sector. The fund deploys capital through instruments such as convertible loans and seed funding rounds into selected portfolio companies (e.g., Delphyr, Bosun, Engager Bio, GlycoTreat).

Product overview

Innovatiefonds Noord-Holland is a regional investment fund that provides financing products to innovative companies in North Holland, Netherlands, with a focus on Life Science & Health. The fund offers financing rounds and convertible loans to portfolio companies. Notable investments include Delphyr (clinical documentation AI), Bosun (AI for software maintenance automation), Engager Bio, and GlycoTreat.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-stage and growth-stage investment financing Provision of seed and growth-stage financing to innovative startups and SMEs in North Holland, Netherlands, addressing capital access gaps for regional ventures.
• Convertible loan financing Convertible loan instrument that converts debt into equity at a later financing round, used to fund early-stage companies such as Delphyr (€275,000 in 2024).
• Life Science & Health investment program Sector-focused investment program targeting life sciences, biotechnology, medical technology, and digital health companies in North Holland. Reached 30th investment milestone in the vertical.

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Direct peers

• InnovationQuarter: Regional development and investment agency for Zuid-Holland providing venture capital, seed financing, and growth capital to innovative companies. Directly comparable as a Dutch regional investment fund targeting innovative startups in a specific province.
• ROM InWest: Regional Development Company for North Holland and Flevoland providing venture capital and loans to innovative SMEs. Highly comparable given the geographic overlap with Innovatiefonds Noord-Holland and similar mandate to fund innovation in the same province.
• BOM (Brabantse Ontwikkelings Maatschappij): Regional development agency for North Brabant providing early-stage and growth capital to innovative companies. Comparable as a Dutch provincial investment fund with a similar mission of stimulating regional innovation ecosystems.
• Oost NL: Regional development agency for Gelderland and Overijssel providing capital, knowledge, and network support to innovative SMEs. Directly comparable as a Dutch regional investment vehicle funding early-stage companies in a specific geography.
• SHIFT Invest: Dutch early-stage impact investor focused on sustainability, circular economy, and AgriFood startups. Highly comparable given the overlap in sustainability and circular economy thematic focus and Dutch early-stage ticket sizes.
• Health~Holland: Dutch top sector organization coordinating public-private partnerships in Life Sciences & Health. Comparable given the overlapping focus on stimulating LS&H innovation in the Netherlands, though Health~Holland is primarily a coordinator rather than a direct investor.
• Thuja Capital: Dutch venture capital firm focused on life sciences and health tech investments, particularly early-stage biotech and medtech. Comparable given the Dutch base and early-stage LS&H focus that mirrors Innovatiefonds' specialized vertical mandate.

Broad incumbents

• Invest-NL: Dutch national impact investor funded by the Ministry of Finance, providing capital to innovative and sustainable companies across the Netherlands. Comparable as a Dutch public-backed investor in innovation but operates at much larger scale across all provinces.
• Forbion: Dutch-headquartered life sciences venture capital firm managing multiple funds across biotech and medtech stages. Comparable given the Dutch base and life sciences focus, but operates at significantly larger scale with pan-European reach.
• EIT Health: European public-private partnership supporting innovation in health and life sciences, including investment activities across Europe. Comparable as a health-focused investor but with broader geographic scope and different funding mechanisms.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments55 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovatiefonds Noord-Holland